Latest analysis of the ELIANA trial for acute lymphocytic leukemia

Dr Stefan Grupp gives a press conference at ASH 2018 about the ELIANA trial.

He diescribes how tisagenlecleucel continues to show durable remissions in paediatric and young patients with relapsed or treatment-resistant acute lymphocytic leukaemia.

Watch his interview with ecancer here:

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php